A Bionic Thermosensitive Sustainable Delivery System for Reversing the Progression of Osteoarthritis by Remodeling the Joint Homeostasis
Advanced Healthcare Materials · 2024-06 · 13 (16)
DOI: 10.1002/adhm.202303792 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 29.03.2024. Verfasst von Min-Ji Tong und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, China. Hauptthemen laut MEDLINE: Osteoarthritis, Chondrocytes, Homeostasis, Nanoparticles. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanghai Hospital Development Center Foundation.
Abstract (Originalsprache)
Although the pathogenesis of osteoarthritis (OA) is unclear, inflammatory cytokines are related to its occurrence. However, few studies focused on the therapeutic strategies of regulating joint homeostasis by simultaneously remodeling the anti‐inflammatory and immunomodulatory microenvironments. Fibroblast growth factor 18 (FGF18) is the only disease‐modifying OA drug (DMOAD) with a potent ability and high efficiency in maintaining the phenotype of chondrocytes within cell culture models. However, its potential role in the immune microenvironment remains unknown. Besides, information on an optimal carrier, whose interface and chondral‐biomimetic microenvironment mimic the native articular tissue, is still lacking, which substantially limits the clinical efficacy of FGF18. Herein, to simulate the cartilage matrix, chondroitin sulfate (ChS)‐based nanoparticles (NPs) are integrated into poly(D, L‐lactide)‐poly(ethylene glycol)‐poly(D, L‐lactide) (PLEL) hydrogels to develop a bionic thermosensitive sustainable delivery system. Electrostatically self‐assembled ChS and ε‐poly‐l‐lysine (EPL) NPs are prepared for the bioencapsulation of FGF18. This bionic delivery system suppressed the inflammatory response in interleukin‐1β (IL‐1β)‐mediated chondrocytes, promoted macrophage M2 polarization, and inhibited M1 polarization, thereby ameliorating cartilage degeneration and synovitis in OA. Thus, the ChS‐based hydrogel system offers a potential strategy to regulate the chondrocyte‐macrophage crosstalk, thus re‐establishing the anti‐inflammatory and immunomodulatory microenvironment for OA therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedic Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
- Department of Orthopedic Surgery, Minhang Hospital, Fudan University, Shanghai, 201100, China.
- Department of Orthopedic Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, China.
ORCID-Profile: Min-Ji Tong, Xiao-Fan Yin
Förderung
- National Natural Science Foundation of China
- Shanghai Hospital Development Center Foundation
Zitieren
APA
Tong, M. J., Song, M. X., Liu, Z., Yu, W., Wang, C. Z., Cai, C. D., Zhang, Y. K., Zhang, Y. Q., Wang, L. P., Zhu, Z. Z., Yin, X. F., & Yan, Z. Q. (2024). A Bionic Thermosensitive Sustainable Delivery System for Reversing the Progression of Osteoarthritis by Remodeling the Joint Homeostasis. Advanced Healthcare Materials, 13(16). https://doi.org/10.1002/adhm.202303792
Vancouver
Tong MJ, Song MX, Liu Z, Yu W, Wang CZ, Cai CD, et al. A Bionic Thermosensitive Sustainable Delivery System for Reversing the Progression of Osteoarthritis by Remodeling the Joint Homeostasis. Advanced Healthcare Materials. 2024;13(16). doi:10.1002/adhm.202303792
BibTeX
@article{Tong2024,
author = {Tong, Min-Ji and Song, Meng-Xiong and Liu, Zhe and Yu, Wei and Wang, Chen-Zhong and Cai, Chuan-Dong and Zhang, Ying-Kai and Zhang, Yue-Qi and Wang, Li-Peng and Zhu, Zhen-Zhong and Yin, Xiao-Fan and Yan, Zuo-Qin},
title = {A Bionic Thermosensitive Sustainable Delivery System for Reversing the Progression of Osteoarthritis by Remodeling the Joint Homeostasis},
journal = {Advanced Healthcare Materials},
year = {2024},
volume = {13},
number = {16},
doi = {10.1002/adhm.202303792}
}
EUVIMED